Clinical Trials Register

Trials with a EudraCT protocol (873)
Paediatric studies in scope of Art45 of the Paediatric Regulation (46)

873 result(s) found for: Anemia. Displaying page 12 of 44.

EudraCT Number: 2018-001320-19

Sponsor Protocol Number: CTX001-121

Start Date*: 2018-12-05

Sponsor Name:Vertex Pharmaceuticals Incorporated

Full Title: A Phase 1/2/3 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Severe Sick...

Medical condition: Severe Sickle Cell Disease (SCD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10010331 - Congenital, familial and genetic disorders	10040641	Sickle cell anaemia	PT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: BE (Trial now transitioned) GB (GB - no longer in EU/EEA) DE (Completed) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2008-006713-25	Sponsor Protocol Number: ASSENTE	Start Date*: 2008-09-23
Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS)
Full Title: A SINGLE-ARM PILOT STUDY WITH LOW-DOSE RITUXIMAB PLUS STANDARD ORAL PREDNISONE IN IDIOPATHIC AUTOIMMUNE HEMOLYTIC ANEMIA
Medical condition: ANEMIE EMOLITICHE AUTOIMMUNI IDIOPATICHE
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)

EudraCT Number: 2016-004779-39

Sponsor Protocol Number: NH19708

Start Date*: 2018-02-26

Sponsor Name:Roche Farma S.A(Soc unipersonal)que realiza el ensayo en España y que actua como representante F.Hoffmann-La Roche LTD.

Full Title: AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASCERTAIN THE OPTIMAL STARTING DOSE OF MIRCERA® GIVEN SUBCUTANEOUSLY FOR THE MAINTENANCE TREATMENT OF ANEMIA IN PEDIATRIC PATIENTS WITH CHRONIC KIDNE...

Medical condition: Chronic renal anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004851	10058132	Renal anemia	LLT
	20.0	100000004851	10072870	Chronic anemia	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed) LT (Completed) HU (Completed) FR (Completed) PL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2007-002380-27

Sponsor Protocol Number: ML21040

Start Date*: 2007-09-05

Sponsor Name:Roche s.r.o.

Full Title: A single arm open label study to assess the efficacy, safety and tolerability and of once-monthly administration of intravenous C.E.R.A. for the maintanance of haemoglobin levels in dialysis patien...

Medical condition: Chronic renal anaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10058123	Renal anaemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2011-006253-29

Sponsor Protocol Number: CLI00070

Start Date*: 2012-07-31

Sponsor Name:Cerus Corporation

Full Title: A Randomized Controlled Double-Blind Phase 3 Study to Assess Characteristics of S-303 Treated RBC Components and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

Medical condition: Acute anemia secondary to cardiovascular surgery.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10022117 - Injury, poisoning and procedural complications	10054312	Anemia postoperative	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2016-000609-36	Sponsor Protocol Number: FIFERM03	Start Date*: 2019-12-16
Sponsor Name:Hospital Vall d´Hebrón
Full Title: Study of the use of Liposomal Iron in the treatment of iron deficiency anemia in pregnancy and puerperium
Medical condition: Iron deficiency anemia
Disease:
Population Age: Adults		Gender: Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2011-001664-22	Sponsor Protocol Number: 2011-001664-22	Start Date*: 2011-12-22
Sponsor Name:Medizinische Universität Wien - Universitätsklinik für Frauenheilkunde
Full Title: A prospective, randomized, multicenter study to evaluate the impact of Darbepoetin alfa in combination with Ferric(III)-Carboxymaltose in comparison to Darbepoetin alfa and Ferric(III)-Carboxymalto...
Medical condition: This is a prospective, multicenter, randomized, comparative, parallel group, phase IV study to assess the efficacy and safety of FCM 800mg or Darbepoetin alfa 500µg or the combination of FCM 800mg ...
Disease:
Population Age: Adults, Elderly		Gender: Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2007-003679-37

Sponsor Protocol Number: ML21349

Start Date*: 2007-09-04

Sponsor Name:Roche a/s

Full Title: A single arm, open label study to assess the efficacy, safety, and tolerability of once-monthly administration of intravenous C.E.R.A. for the maintenance of haemoglobin levels in haemodialysis p...

Medical condition: Chronic renal anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10058124	Nephrogenic anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2006-005916-29

Sponsor Protocol Number: IFEROS V5-1

Start Date*: 2007-10-29

Sponsor Name:Westpfalz-Klinikum GmbH

Full Title: IFEROS – Influence of intravenous iron therapeutics on oxidative stress in hemodialysis patients

Medical condition: stable patients on hemodialysis with renal anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10019480	Hemodialysis	LLT
	9.1		10058132	Renal anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-004014-13

Sponsor Protocol Number: ML21145

Start Date*: 2008-05-27

Sponsor Name:ROCHE

Full Title: Etude française, randomisée, controlée, parallèle, en ouvert, multicentrique, comparant le maintien du taux d’hémoglobine avec une administration mensuelle de C.E.R.A. (activateur continu du récept...

Medical condition: Patients insuffisants rénaux chroniques hémodialysés

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10054353	Chronic renal failure anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-002031-29

Sponsor Protocol Number: R7257-RAA-1947

Start Date*: 2020-11-05

Sponsor Name:Regeneron Pharmaceuticals, Inc.

Full Title: A PHASE 1/2 STUDY OF REGN7257 (ANTI-INTERLEUKIN 2 RECEPTOR SUBUNIT GAMMA [IL2RG] MONOCLONAL ANTIBODY) IN PATIENTS WITH SEVERE APLASTIC ANEMIA THAT IS REFRACTORY TO OR RELAPSED ON IMMUNOSUPPRESSIVE ...

Medical condition: SEVERE APLASTIC ANEMIA

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004851	10002274	Anemia aplastic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2009-014455-68

Sponsor Protocol Number: HOVON103AMLTosedostat

Start Date*: 2010-08-16

Sponsor Name:HOVON Foundation

Full Title: A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral tosedostat to standard induction therapy in AML and RAEB ≥ 66 years and ...

Medical condition: patients ≥ 66 years.with a confirmed diagnosis of o AML (not APL) (see appendix A) or o refractory anemia with excess of blasts (RAEB) with an IPSS score ≥ 1.5 OR Patients of any age ≥ 1...

Disease:	Version	SOC Term	Classification Code	Term	Level
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10000886	Acute myeloid leukemia	LLT
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10037803	RAEB	LLT
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10000880	Acute myeloid leukaemia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) BE (Completed) NO (Completed)

Trial results: (No results available)

EudraCT Number: 2007-001377-28

Sponsor Protocol Number: 27577

Start Date*: 2008-06-11

Sponsor Name:Merck Serono International S.A.

Full Title: Phase IV, one-day, single blood sampling study to investigate severe thrombocytopenia and autoimmune diseases in psoriasis subjects previously treated with RAPTIVA® (efalizumab) in the framework of...

Medical condition: Adult patients with moderate to severe chronic plaque psoriasis -- who have failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosp...

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10061664	Autoimmune disorder	LLT
	9.1		10025139	Lupus erythematosus systemic	LLT
	9.1		10047888	Wegener's granulomatosis	LLT
	9.1		10002817	Antiphospholipid syndrome	LLT
	9.1		10040767	Sjogren's syndrome	LLT
	9.1		10039073	Rheumatoid arthritis	LLT
	9.1		10028245	Multiple sclerosis	LLT
	9.1		10045228	Type I diabetes mellitus	LLT
	9.1		10011401	Crohn's disease	LLT
	9.1		10009900	Colitis ulcerative	LLT
	9.1		10003827	Autoimmune hepatitis	LLT
	9.1		10049046	Autoimmune thyroiditis	LLT
	9.1		10003822	Autoimmune haemolytic anaemia NOS	LLT
	9.1		10034697	Pernicious anemia	LLT
	9.1		10028417	Myasthenia gravis	LLT
	9.1		10018620	Goodpasture's syndrome	LLT
	9.1		10018766	Guillain Barre syndrome	LLT
	9.1		10043554	Thrombocytopenia	LLT
	9.1		10037153	Psoriasis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) DE (Prematurely Ended) AT (Prematurely Ended) NL (Prematurely Ended) PT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-000074-79

Sponsor Protocol Number: 20050210

Start Date*: 2006-05-19

Sponsor Name:Amgen Ltd

Full Title: A Multicenter, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis.

Medical condition: Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	7.0		10049105		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2016-000541-31

Sponsor Protocol Number: 200807

Start Date*: 2016-12-02

Sponsor Name:GlaxoSmithKline Research & Development Ltd

Full Title: A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in dialysis subjects with anemia associated with chronic kidney disease to evalu...

Medical condition: Anemia associated with chronic kidney disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10038359 - Renal and urinary disorders	10064848	Chronic kidney disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) BE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) CZ (Completed) DE (Completed) SE (Completed) PT (Completed) ES (Completed) NL (Completed) AT (Completed) GR (Completed) FR (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2018-003459-39

Sponsor Protocol Number: AG348-C-011

Start Date*: 2019-04-10

Sponsor Name:Agios Pharmaceuticals, Inc.

Full Title: An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies

Medical condition: Pyruvate Kinase Deficiency Haemolytic anaemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10010331 - Congenital, familial and genetic disorders	10037682	Pyruvate kinase deficiency anaemia	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) FR (Completed) IE (Completed) NL (Completed) DE (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2009-013094-17

Sponsor Protocol Number: HOVON103AMLLEN

Start Date*: 2010-04-13

Sponsor Name:HOVON Foundation

Full Title: A randomized phase II multicenter study with a safety run-in to assess the tolerability and efficacy of the addition of oral lenalidomide to standard induction therapy in AML and RAEB ≥ 66 years an...

Disease:	Version	SOC Term	Classification Code	Term	Level
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10000886	Acute myeloid leukemia	LLT
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10037803	RAEB	LLT
	15.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10000880	Acute myeloid leukaemia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) BE (Completed) NO (Completed)

Trial results: (No results available)

EudraCT Number: 2015-004813-26

Sponsor Protocol Number: GCP#04.01.020/030

Start Date*: 2016-03-14

Sponsor Name:Gamida Cell Ltd

Full Title: Long Term Follow Up for Patients who have received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells

Medical condition: High risk haematological malignancies Hemoglobinopathies

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	100000004864	10025316	Lymphoma NOS	LLT
	18.1	100000004864	10000845	Acute lymphoblastic leukemia	LLT
	18.1	100000004864	10000886	Acute myeloid leukemia	LLT
	18.1	100000004850	10054658	Thalassemia	LLT
	18.1	100000004864	10009015	Chronic myeloid leukemia	LLT
	18.1	100000004850	10040645	Sickle cell disease NOS	LLT
	18.1	100000004864	10028534	Myelodysplastic syndrome NOS	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: (No results available)

EudraCT Number: 2021-003333-11

Sponsor Protocol Number: AG348-C-023

Start Date*: 2022-04-25

Sponsor Name:Agios Pharmaceuticals, Inc.

Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Subjects With Pyruvate Kinase Deficiency Who Are Not Regular...

Medical condition: Pyruvate Kinase Deficiency

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10010331 - Congenital, familial and genetic disorders	10037682	Pyruvate kinase deficiency anaemia	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Ongoing) DE (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) NL (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2015-000484-13

Sponsor Protocol Number: AG-348-C-003

Start Date*: 2015-07-10

Sponsor Name:Agios Pharmaceuticals Inc

Full Title: A Phase 2, Open Label, Randomized, Dose Ranging, Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of AG-348 in Adult Patients with Pyruvate Kinase Deficiency

Medical condition: Pyruvate Kinase Deficiency

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10010331 - Congenital, familial and genetic disorders	10037682	Pyruvate kinase deficiency anaemia	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) NL (Completed) IT (Completed)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Anemia